Literature DB >> 2169423

Stereoselectivity and subtype of the opiate receptor involved in stress-induced hypertension.

I Jiménez1, T Iglesias, J A Fuentes.   

Abstract

Naloxone enantiomorphs were given intracerebroventricularly (i.c.v.) to rats socially deprived for a brief period of time (7-14 days) in order to ascertain the mediation of central opiate receptors in the reversal effect of opiate antagonists on the high systolic blood pressure induced by this type of stress. While the active enantiomorph ((-)-naloxone, 20 nmol per rat) lowered the elevated blood pressure, the (+)-enantiomorph (which shows a 10,000-fold lower affinity for opiate receptors) had no effect. Additionally, the antihypertensive effect induced by i.c.v. administration of an antagonist of the mu-opiate receptor (beta-funaltrexamine, 20 nmol per rat), but not of the delta-opiate receptor (ICI 174,864, 15 nmol per rat) pointed to the involvement of mu-opiate receptors as the endogenous component of the hypertensive response of rats to stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169423     DOI: 10.1016/0014-2999(90)90505-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period.

Authors:  Alberto Loizzo; Stefano Loizzo; Luisa Lopez; Antonio d'Amore; Paolo Renzi; Santi Spampinato; Simonetta Di Carlo; Antonella Bacosi; Piergiorgio Zuccaro; Roberta Pacifici
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.

Authors:  M L Hernández; J J Fernández-Ruiz; M Navarro; R de Miguel; M Cebeira; L Vaticón; J A Ramos
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  Preproenkephalin RNA increases in the hypothalamus of rats stressed by social deprivation.

Authors:  T Iglesias; S Montero; M J Otero; L Parra; J A Fuentes
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.